These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6390963)

  • 41. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract]   [Full Text] [Related]  

  • 42. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of isoniazid and of a complex compound of cobalt with pyridoxine on rabbits infected with tuberculosis].
    Sodikov ES; Gapon'ko LA
    Farmakol Toksikol; 1972; 35(2):234-7. PubMed ID: 5017977
    [No Abstract]   [Full Text] [Related]  

  • 44. [Experimental studies of parmidin (pyridinolcarbamate) effect on microvascular permeability of the lungs, skin and mesentery].
    Gorizontoba MP; Shvarts GIa
    Biull Eksp Biol Med; 1979 Sep; 88(9):272-5. PubMed ID: 519015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract]   [Full Text] [Related]  

  • 46. [Studies on the relationship between the proliferation rate of infecting tubercle bacilli and the effectiveness of chemotherapy. II. Observations in various types of infection experiment (author's transl)].
    Kondo E; Kanai K
    Kekkaku; 1977 Oct; 52(10):475-9. PubMed ID: 414001
    [No Abstract]   [Full Text] [Related]  

  • 47. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
    Orbetzova V; Jurukova Z; Orbetzova M
    Artery; 1980; 8(6):560-9. PubMed ID: 7259535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Editorial: Antituberculosis chemotherapy: a resume of the rationale.
    Dhar S
    J Indian Med Assoc; 1973 Jun; 60(11):437-9. PubMed ID: 4127203
    [No Abstract]   [Full Text] [Related]  

  • 49. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of several immunoactive agents on the course of kidney tuberculosis].
    Bellendir EN; Nakonechnyĭ GD; Peschanskaia IN; Salmagambetov IU
    Probl Tuberk; 1976 Dec; (12):65-9. PubMed ID: 1005407
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparative histopathological studies of the results of continuous and intermittent treatment with rifampicin in experimental tuberculosis].
    Diaconiţă G; Luţescu L
    Ftiziologia; 1974 May; 23(3):269-80. PubMed ID: 4601851
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of individual drugs in the chemotherapy of tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of splenin on protein-synthetising function of the liver during treatment of experimental tuberculosis with large doses of isoniazid].
    Afrikanov II; Il'inykh AP
    Probl Tuberk; 1975; (7):74-8. PubMed ID: 1215372
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
    Spesivtseva VG; Frenkel' VKh; Mamaeva GG; Sokolovskiĭ GA; Kukes VG
    Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA;
    Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical manifestations of tuberculosis in renal transplant patients.
    Park SB; Joo I; Park YI; Suk J; Cho WH; Park CH; Kim HC
    Transplant Proc; 1996 Jun; 28(3):1520-2. PubMed ID: 8658768
    [No Abstract]   [Full Text] [Related]  

  • 59. Three-in-one TB drug approved.
    Posit Aware; 1995; ():5. PubMed ID: 11362378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Psychophysiological aspect of the therapeutic use of pyridinolcarbamate].
    Sidorenko GI; Borisova GS; Sidorenko ER; Polonetskii LZ; Gelis LG
    Kardiologiia; 1983 Mar; 23(3):66-71. PubMed ID: 6855067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.